The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. SW Dubrey, K Cha, J Anderson, B Chamarthi, J Reisinger, M Skinner, ... QJM: monthly journal of the Association of Physicians 91 (2), 141-157, 1998 | 693 | 1998 |
Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures P Underwood, R Askari, S Hurwitz, B Chamarthi, R Garg Diabetes care 37 (3), 611-616, 2014 | 227 | 2014 |
Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin–angiotensin system in humans B Chamarthi, GH Williams, V Ricchiuti, N Srikumar, PN Hopkins, ... American journal of hypertension 24 (10), 1143-1148, 2011 | 200 | 2011 |
Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis B Chamarthi, SW Dubrey, K Cha, M Skinner, RH Falk American Journal of Cardiology 80 (9), 1242-1245, 1997 | 160 | 1997 |
Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus GA Walford, J Davis, AS Warner, RJ Ackerman, LK Billings, B Chamarthi, ... Metabolism 62 (12), 1772-1778, 2013 | 84 | 2013 |
A mechanism for salt-sensitive hypertension: abnormal dietary sodium-mediated vascular response to angiotensin-II B Chamarthi, JS Williams, GH Williams Journal of hypertension 28 (5), 1020-1026, 2010 | 70 | 2010 |
TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the … S Srinivasan, V Kaur, B Chamarthi, KR Littleton, L Chen, AK Manning, ... Diabetes Care 41 (3), 554-561, 2018 | 48 | 2018 |
Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension JS Williams, B Chamarthi, MO Goodarzi, LH Pojoga, B Sun, AE Garza, ... American journal of hypertension 25 (7), 812-817, 2012 | 46 | 2012 |
Timed bromocriptine‐QR therapy reduces progression of cardiovascular disease and dysglycemia in subjects with well‐controlled type 2 diabetes mellitus B Chamarthi, JM Gaziano, L Blonde, A Vinik, RE Scranton, M Ezrokhi, ... Journal of Diabetes Research 2015 (1), 157698, 2015 | 41 | 2015 |
Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses B Sun, JS Williams, L Pojoga, B Chamarthi, J Lasky-Su, BA Raby, ... Journal of the Renin-Angiotensin-Aldosterone System 12 (4), 564-571, 2011 | 36 | 2011 |
Replication and meta-analysis of the gene-environment interaction between body mass index and the interleukin-6 promoter polymorphism with higher insulin resistance PC Underwood, B Chamarthi, JS Williams, B Sun, A Vaidya, BA Raby, ... Metabolism 61 (5), 667-671, 2012 | 35 | 2012 |
Urinary free cortisol: an intermediate phenotype and a potential genetic marker for a salt-resistant subset of essential hypertension B Chamarthi, NS Kolatkar, SC Hunt, JS Williams, EW Seely, NJ Brown, ... The Journal of Clinical Endocrinology & Metabolism 92 (4), 1340-1346, 2007 | 35 | 2007 |
Comparison of insulin sensitivity measures in South Asians S Trikudanathan, A Raji, B Chamarthi, EW Seely, DC Simonson Metabolism 62 (10), 1448-1454, 2013 | 32 | 2013 |
Predictors of plasma and urinary catecholamine levels in normotensive and hypertensive men and women AR Saxena, B Chamarthi, GH Williams, PN Hopkins, EW Seely Journal of human hypertension 28 (5), 292-297, 2014 | 29 | 2014 |
Early identification of individuals with poorly controlled diabetes undergoing elective surgery: improving A1C testing in the preoperative period P Underwood, J Seiden, K Carbone, B Chamarthi, A Turchin, AM Bader, ... Endocrine practice 21 (3), 231-236, 2015 | 28 | 2015 |
Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus PC Underwood, B Chamarthi, JS Williams, A Vaidya, R Garg, GK Adler, ... The Journal of Clinical Endocrinology & Metabolism 97 (10), 3775-3782, 2012 | 28 | 2012 |
Impact of bromocriptine-QR therapy on cardiovascular outcomes in type 2 diabetes mellitus subjects on metformin B Chamarthi, M Ezrokhi, D Rutty, AH Cincotta Postgraduate Medicine 128 (8), 761-769, 2016 | 27 | 2016 |
Postoperative complications and impact of diabetes mellitus severity on revision total knee arthroplasty A Gu, C Wei, HN Robinson, SA Sobrio, J Liu, TP Sculco, PK Sculco The Journal of Knee Surgery 33 (03), 228-234, 2020 | 25 | 2020 |
Effect of bromocriptine-QR therapy on glycemic control in subjects with type 2 diabetes mellitus whose dysglycemia is inadequately controlled on insulin B Chamarthi, AH Cincotta Postgraduate Medicine 129 (4), 446-455, 2017 | 25 | 2017 |
The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes GA Walford, N Colomo, JN Todd, LK Billings, M Fernandez, B Chamarthi, ... PLoS One 10 (3), e0121553, 2015 | 24 | 2015 |